William F Dall'Acqua Selected Research

William F Dall'Acqua Research Topics

11	Neoplasms (Cancer) 01/2021 - 05/2005
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2017
2	Lung Diseases (Lung Disease) 01/2020 - 01/2019
2	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 01/2015
2	Infections 01/2017 - 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2020
1	Kidney Diseases (Kidney Disease) 01/2020
1	Fibrosis (Cirrhosis) 01/2019
1	Idiopathic Pulmonary Fibrosis 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Human Influenza (Influenza) 01/2016
1	Pneumonia (Pneumonitis) 01/2016

4	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2016
4	Pharmaceutical PreparationsIBA 10/2020 - 01/2019
3	Immunoglobulin FragmentsIBA 01/2020 - 10/2018
3	AntibodiesIBA 01/2020 - 01/2016
3	AntigensIBA 10/2018 - 01/2016
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2007 - 05/2005
2	Annexin A1IBA 01/2021 - 01/2020
2	Immunoconjugates (Immunoconjugate)IBA 01/2019 - 06/2010
2	Monoclonal AntibodiesIBA 01/2019 - 10/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2017 - 01/2016
1	LigandsIBA 10/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Biological ProductsIBA 01/2020
1	Dinoprostone (PGE2)FDA Link 01/2019
1	CollagenIBA 01/2019
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2019
1	interleukin-21 (interleukin 21)IBA 01/2019
1	Indicators and Reagents (Reagents)IBA 10/2018
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 10/2018
1	Trastuzumab (Herceptin)FDA Link 01/2017
1	imgatuzumabIBA 01/2017
1	VaccinesIBA 01/2016
1	Hemagglutinins (Hemagglutinin)IBA 01/2016
1	EpitopesIBA 01/2016
1	Broadly Neutralizing AntibodiesIBA 01/2016
1	Neutralizing AntibodiesIBA 01/2016
1	anifrolumabIBA 01/2015

9	Therapeutics 01/2019 - 05/2005